Association between antipsychotics and cardiovascular adverse events
Systematic review
Versandkostenfrei!
Versandfertig in 6-10 Tagen
33,99 €
inkl. MwSt.
PAYBACK Punkte
17 °P sammeln!
There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.
Andere Kunden interessierten sich für
